Calcium Channel Inhibitor

Calcium Channel Inhibitors (183):

Cat. No.	Product Name	Effect	Purity

HY-13433

Thapsigargin	Inhibitor	99.95%
Thapsigargin, an endoplasmic reticulum (ER) stress inducer, is an inhibitor of microsomal Ca²⁺-ATPase.

HY-W009724

2-Aminoethyl diphenylborinate	Inhibitor	98.36%
2-Aminoethyl diphenylborinate (2-APB) is a cell-permeable inhibitor of IP3R.

HY-10805

Almorexant	Inhibitor	99.71%
Almorexant (ACT 078573) is an orally active, potent and competitive dual orexin receptor antagonist, with K_d values of 1.3 nM (OX1) and 0.17 nM (OX2), respectively.

HY-13750

Ebselen	Inhibitor	99.58%
Ebselen (SPI-1005), a glutathione peroxidase mimetic, is a potent voltage-dependent calcium channel (VDCC) blocker.

HY-N1584

Halofuginone	Inhibitor	99.78%
Halofuginone (RU-19110), a Febrifugine derivative, is a competitive prolyl-tRNA synthetase inhibitor with a K_i of 18.3 nM.

HY-13764

Tetrandrine	Inhibitor	99.90%
Tetrandrine (NSC-77037; d-Tetrandrine) is a bis-benzyl-isoquinoline alkaloid, which inhibits voltage-gated Ca²⁺ current (ICa) and Ca²⁺-activated K⁺ current.

HY-131614

TPC2-A1-N	Inhibitor	99.90%
TPC2-A1-N is a powerful and Ca²⁺-permeable agonist of two pore channel 2 (TPC2), which plays its role by mimicking the physiological actions of NAADP.

HY-A0057

Gabapentin	Inhibitor	≥98.0%
Gabapentin is a potent, orally active P/Q type Ca²⁺ channel blocker.

HY-15553A

Mibefradil dihydrochloride	Inhibitor	98.78%
Mibefradil dihydrochloride (Ro 40-5967 dihydrochloride) is a calcium channel blocker with moderate selectivity for T-type Ca²⁺ channels (IC₅₀s of 2.7 μM and 18.6 μM for T-type and L-type currents, respectively).

HY-B0309

Felodipine	Inhibitor	99.35%
Felodipine, a dihydropyridine, is a potent, vasoselective calcium channel antagonist.

HY-12507

GSK-7975A	Inhibitor	99.79%
GSK-7975A is a potent and orally available CRAC channel inhibitor.

HY-B0265

Nimodipine	Inhibitor	99.76%
Nimodipine (BAY-e 9736) is an orally active, well-tolerated and light-sensitive dihydropyridine calcium antagonist.

HY-17401

Ranolazine dihydrochloride	Inhibitor	99.79%
Ranolazine dihydrochloride (CVT 303 dihydrochloride) is an anti-angina drug that achieves its effects by inhibiting the late phase of inward sodium current (I_Na and I_Kr with IC₅₀ values of 6 μM and 12 μM, respectively) without affecting heart rate or blood pressure (BP).

HY-N1584A

Halofuginone hydrobromide	Inhibitor	99.55%
Halofuginone (RU-19110) hydrobromid, a Febrifugine derivative, is a competitive prolyl-tRNA synthetase inhibitor with a K_i of 18.3 nM.

HY-B0280

Ranolazine	Inhibitor	99.72%
Ranolazine (CVT 303) is an anti-angina drug that achieves its effects by inhibiting the late phase of inward sodium current (I_Na and I_Kr with IC₅₀ values of 6 μM and 12 μM, respectively) without affecting heart rate or blood pressure (BP).

HY-12515A

Nicardipine hydrochloride	Inhibitor	99.80%
Nicardipine hydrochloride (YC-93) is a calcium channel blocker with an IC₅₀ of 1 μM for blocking cardiac calcium channels.

HY-12542A

Dantrolene sodium hemiheptahydrate	Inhibitor	≥98.0%
Dantrolene sodium hemiheptahydrate is a skeletal muscle relaxant which acts by blocking muscle contraction beyond the neuromuscular junction.

HY-101379A

8-Bromo-cGMP sodium	Inhibitor	99.07%
8-Bromo-cGMP sodium, a membrane-permeable analogue of cGMP, is a PKG (protein kinase G) activator.

HY-103316

trans-Ned 19	Inhibitor	99.53%
trans-Ned 19, a NAADP antagonist and TPC blocker, suppresses the calcium signal in human umbilical vein endothelial cells (HUVEC) and the rat aorta relaxation in response to low histamine concentrations.

HY-B0122

Topiramate	Inhibitor	≥98.0%
Topiramate (McN 4853) is a broad-spectrum antiepileptic agent.

Name
Email *

	Sorry, but the email address you supplied was invalid.